Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
Analgesics is failing to record a strong performance in Lithuania in 2023; following the pandemic years, sales are stagnating, reflecting the saturated market and consumer base. In addition, a growing scepticism and concern about the overreliance on…
Analgesics continues to achieve strong value growth in North Macedonia in 2023 as a result of strong consumer demand for systemic analgesics, especially adult ibuprofen, adult acetaminophen and adult aspirin. Topical analgesics are outperforming…
Diclofenac and naproxen are non-steroidal anti-inflammatory analgesics used to relieve mild pain. Both categories saw retail current value sales surge in 2022. Retail current value sales are set to continue to grow over 2023 in both categories,…
Consumer health in Latvia continues to recover from the pandemic in 2023, with major categories seeing demand patterns rebalance as lifestyles shift back normality. Economic uncertainty is prevailing with inflation remaining high in 2023, a trend…
2023 marks the final year that the outbreak of COVID-19 impacts results. Product areas that gained sales due to the COVID-19 pandemic are returning to purchasing levels and behaviours seen before 2020. Similarly, those negatively impacted by the…
Despite higher standards of living in North Macedonia, economic challenges resulting in low disposable incomes remain, with the situation further exacerbated by the ongoing war in Ukraine. This has led to double-digit inflation, which is increasing…
Consumer health in Slovakia is affected by changes in purchasing behaviour as a result of the fading Coronavirus (COVID-19) pandemic, the effects of the war in Ukraine and a cost of living crisis amid high inflation. However, the issue of high…
Cough, cold and allergy (hay fever) remedies in Latvia is registering moderate growth in 2023 as the category begins to stabilise post-pandemic. Retail value sales rebounded strongly 2022 after two years of decline, with lifestyles shifting back to…
2023 marks the year when the cough and cold landscape is set to lose its uplift due to COVID-19, returning to a level closer to that seen pre-pandemic. Sales have continued to benefit from harsh seasonal colds and the flu season of 2022-2023.…
Cough, cold and allergy (hay fever) remedies is seeing slower growth in 2023 due to a shorter cold season caused by milder winter 2022/2023. The exception is antihistamines, which continues to grow at a solid rate due to high consumer demand amidst…